Oculis Holding AG (OCS) Return on Assets (2023 - 2026)
Oculis Holding AG's (OCS) quarterly Return on Assets came in at 0.69% in Q1 2026, up 59.0% year-on-year from 0.44% in Q1 2025, and up 16.77% quarter-over-quarter from 0.83% in Q4 2025.
Oculis Holding AG (OCS) Return on Assets (2023 - 2026) Analysis & Trends
Oculis Holding AG's Return on Assets history runs 4 years deep, the most recent figure standing at 0.69% for Q1 2026.
- On a quarterly basis, Return on Assets rose 59.0% year-over-year to 0.69% in Q1 2026; TTM through Mar 2026 was 0.69%, a 59.0% increase from a year earlier, with the FY2025 full-year figure at 0.01%, changed 0.0% from the prior year.
- Return on Assets climbed to 0.69% in Q1 2026 per OCS's latest filing, from 0.83% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q1 2024 and bottomed at 1.65% in Q4 2024.
- The 4-year median for Return on Assets is 0.83% (2025), against an average of 0.73%.
- Across the five-year window, Return on Assets slumped 165 bps in 2024 and soared 82 bps in 2025, its largest moves.
- Year by year, Return on Assets stood at 0.01% in 2023, then slumped by 23198 bps to 1.65% in 2024, then soared by 50 bps to 0.83% in 2025, then climbed by 17 bps to 0.69% in 2026.
- Per Business Quant, the three latest OCS Return on Assets figures stand at 0.69% (Q1 2026), 0.83% (Q4 2025), and 0.99% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -0.80% |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 0.00% |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | -0.83% |
| Sep 30, 2025 | -0.99% |
| Jun 30, 2025 | -1.05% |
| Mar 31, 2025 | -1.28% |
| Dec 31, 2024 | -1.65% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |